Literature DB >> 33561293

Fitness and prostate cancer screening, incidence, and mortality: Results from the Henry Ford Exercise Testing (FIT) Project.

Cara Reiter-Brennan1,2, Omar Dzaye1,2,3, Mouaz H Al-Mallah4, Zeina Dardari1, Clinton A Brawner5, Lois E Lamerato6, Steven J Keteyian5, Jonathan K Ehrman5, Michael J Blaha1, Kala Visvanathan7, Catherine H Marshall1,7.   

Abstract

BACKGROUND: The relation between cardiorespiratory fitness (CRF) and prostate cancer is not well established. The objective of this study was to determine whether CRF is associated with prostate cancer screening, incidence, or mortality.
METHODS: The Henry Ford Exercise Testing Project is a retrospective cohort study of men aged 40 to 70 years without cancer who underwent physician-referred exercise stress testing from 1995 to 2009. CRF was quantified in metabolic equivalents of task (METs) (<6 [reference], 6-9, 10-11, and ≥12 METs), estimated from the peak workload achieved during a symptom-limited, maximal exercise stress test. Prostate-specific antigen (PSA) testing, incident prostate cancer, and all-cause mortality were analyzed with multivariable adjusted Poisson regression and Cox proportional hazard models.
RESULTS: In total, 22,827 men were included, of whom 739 developed prostate cancer, with a median follow-up of 7.5 years. Men who had high fitness (≥12 METs) had an 28% higher risk of PSA screening (95% CI, 1.2-1.3) compared with those who had low fitness (<6 METs. After adjusting for PSA screening, fitness was associated with higher prostate cancer incidence (men aged <55 years, P = .02; men aged >55 years, P ≤ .01), but not with advanced prostate cancer. Among the men who were diagnosed with prostate cancer, high fitness was associated with a 60% lower risk of all-cause mortality (95% CI, 0.2-0.9).
CONCLUSIONS: Although men with high fitness are more likely to undergo PSA screening, this does not fully account for the increased incidence of prostate cancer seen among these individuals. However, men with high fitness have a lower risk of death after a prostate cancer diagnosis, suggesting that the cancers identified may be low-risk with little impact on long-term outcomes.
© 2021 American Cancer Society.

Entities:  

Keywords:  cancer; cardiorespiratory fitness; prostate cancer; prostate-specific antigen

Mesh:

Substances:

Year:  2021        PMID: 33561293     DOI: 10.1002/cncr.33426

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  2 in total

1.  Healthy Lifestyle Benefits Both Cancer and Cardiovascular Disease: More Bang for the Buck.

Authors:  Erin D Michos; Catherine H Marshall
Journal:  JACC CardioOncol       Date:  2021-12-21

2.  Prostate Cancer Incidence and Mortality: Global Status and Temporal Trends in 89 Countries From 2000 to 2019.

Authors:  Le Wang; Bin Lu; Mengjie He; Youqing Wang; Zongping Wang; Lingbin Du
Journal:  Front Public Health       Date:  2022-02-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.